What trends in VMD's earnings suggest for 2025 investments?

**Viemed Healthcare's (VMD) 2025 investment prospects appear positive**, as evidenced by several key trends in their earnings and operational performance: 1. **Revenue Growth**: Viemed Healthcare has demonstrated robust revenue growth, with a 19.6% year-over-year increase in Q4 2024, reaching $60.7 million. This growth trajectory is indicative of a strong market demand for their services and products. 2. **Patient Count Increase**: The company has seen significant increases in its patient counts for ventilator, PAP therapy, and sleep resupply services. These increases, coupled with the expansion of their sales force, suggest a strategic focus on market penetration and customer base growth. 3. **Adjusted EBITDA and Net Income**: Viemed Healthcare has reported a record $51.1 million in adjusted EBITDA for the year ended December 31, 2024. The net income for the same period was $11.3 million, reflecting efficient management and a healthy profit margin. 4. **Cash Flow and Financial Position**: The company's cash flow has been strong, with net cash provided by operating activities totaling $39.1 million for the year ended December 31, 2024. This is a positive sign for investors, indicating the company's ability to generate cash and invest in growth opportunities. 5. **Full Year 2025 Guidance**: Viemed Healthcare has provided guidance for the year ending December 31, 2025, with projected net revenues ranging from $254 million to $265 million. This implies a growth rate of 16% over 2024, suggesting a positive outlook for the company's future earnings. 6. **Stock Forecast and Price Prediction**: While there are varying price predictions, including a potential drop by May 2, 2025, the overall trend and market sentiment appear positive, with a consensus rating of "Buy" and a current market cap of $292 million. In conclusion, Viemed Healthcare's strong revenue growth, increased patient counts, solid financial performance, and positive guidance for 2025 suggest that the company is well-positioned for investors looking for stable and growing healthcare investments. However, investors should also consider the potential risks and market conditions when making investment decisions.